Articles tagged with Nuclear Proteins
A groundbreaking study identifies a direct energy route between mitochondria and the nucleus, supporting gene regulation, chromatin remodeling, and cell differentiation. The finding challenges traditional assumptions about energy transfer in cells and has significant implications for understanding health and disease.
Researchers characterized the structure and function of a protein that regulates sugar and fat levels, finding it can work with an unexpected partner - itself. This partnership may drive the expression of different genes than its usual partner, offering new therapeutic targets for diseases like liver cancer and diabetes.
Researchers developed promising α-synuclein PET tracers that can visualize protein aggregates in living patients, enabling earlier diagnosis and treatment monitoring. Tracers like [18F]C05-05 and [18F]ACI-12589 showed significant results in distinguishing synucleinopathies from healthy controls.
Researchers developed a carbene-catalyzed phthalide ether functionalization method, creating chiral phytovirucides targeting the viral Nia protein. The compounds showed superior antiviral efficacy against Potato virus Y (PVY), with potential for developing new plant viruses management strategies.
A team of researchers from Goethe University and Kiel University has discovered a way to prevent the formation of harmful protein aggregates in cultured cells. The study found that linking TDP-43 with SUMO prevents its aggregation, suggesting a potential new approach for treating ALS and other neurodegenerative diseases.
Researchers developed a novel protein, LSUBP, to enhance uranium extraction from seawater. The engineered protein achieves high adsorption capacity, offering a promising new material for effective uranium extraction.
Three NSF-funded investigations are launching on NASA's SpaceX CRS-32 mission to ISS National Laboratory. Investigations aim to advance pharmaceutical manufacturing, develop new materials, and study active matter in microgravity environment.
A study reveals that Galectin-1 protein, located in fibroblast nuclei, promotes tumor growth and resistance to treatment. The protein regulates gene expression at a specific level, activating KRAS, a key driver of uncontrolled growth and tumor aggressiveness.
Cells dynamically adjust nuclear pore complexes like a retail store opening more checkout lines to regulate genome access. Research findings suggest that protein creation and disposal systems control the amount of NPCs in cells.
Researchers at POSTECH developed a super-photostable organic dye, PF555, to track proteins in cells over extended periods. This breakthrough enables observation of endocytosis and protein interactions, revealing EGFR's active navigation in its environment.
A new universal photocage modification strategy based on thioketal enables real-time live cell subcellular imaging. The thioketal-based probe SiR-EDT exhibits improved dark stability and can be specifically activated by UV-visible light.
Biologists have identified a new type of regulation that influences the expression of about half of all human genes by targeting specific introns. This discovery adds complexity to the process of gene expression and suggests potential therapeutic targets for diseases such as blood cancers and spinal muscular atrophy.
Researchers identify Fam102a as a key regulator of both osteoclast and osteoblast differentiation, leading to enhanced osteoblast formation and bone volume. The study reveals significant protein-protein interactions involving Fam102a and Kpna2, shedding light on the critical molecular interactions involved in bone remodeling.
Researchers at Texas A&M University have uncovered a mechanism behind cancer progression: the stiffening of tumor cell's environment. This spreading causes increased cell proliferation and tumor growth.
Research highlights Nup93's critical role in endothelial cell function and vascular health, with promising findings for new treatments to slow down aging. Low Nup93 levels are associated with inflammation and cellular aging, while restoring its levels can reverse harmful effects.
Researchers discovered that p14<sup>ARF</sup> activates tumor suppression by forming gel-like assemblies in the nucleolus, disrupting ribosome production and cell toxicity. This process contributes to cancer cell death, providing a new mechanism for tumor suppression.
Researchers have developed a 'mini-protein' that targets cancer cells expressing Nectin-4, allowing for direct delivery of radiation to tumours. The treatment shows promise in targeting multiple types of cancers and has the potential to be safe for repeated administrations.
Tobacco plant molecular farming offers advantages over traditional approaches, including lower costs and high-yield production. A comprehensive study addresses the challenge of subcellular localization for recombinant protein production, focusing on ER, vacuole, chloroplast, and apoplast targeting strategies.
A new study reveals a link between senescent cells and the protein HIRA, which helps pack and unpack DNA. The research team discovered that HIRA is necessary for the cells to begin emitting inflammatory molecules, leading to chronic inflammation in the body.
Researchers explore Extracellular signal-regulated kinase 5 (Erk5) and its unique structures regulating autophosphorylation and transcription. Erk5 is involved in angiogenesis, neurogenesis, energy metabolism, tumor growth, and metastasis, making it a potential target for cancer treatment.
A recent study has identified Nup358 as a critical regulator of myeloid cell development, revealing its role in the differentiation process of early progenitors. The findings provide insights into how alterations in Nup358 contribute to blood malignancies and may lead to novel therapies targeting transport machinery like NPCs.
Scientists at St. Jude Children's Research Hospital have designed novel PXR inhibitors that can block the activity of pregnane X receptor, a key regulator of drug metabolism. The study provides new insights into the relationship between compounds that activate and inhibit PXR, with implications for designing more effective therapeutics.
Researchers discovered that protein softness near nuclear-localisation sequence influences entry speed. Softer proteins cross into the nucleus quicker than stiffer ones.
MIT engineers create technique to image bioluminescent molecules in deep tissue with high resolution, enabling detailed studies of brain cell development and communication. The method uses engineered blood vessels that dilate in response to light, allowing researchers to pinpoint the source of light.
Researchers use a new method to analyze the structural properties of proteins under extreme pressure, revealing new insights into their native structures. The technique, which applies 3,000 bar of pressure, allows for the observation of protein states that would be invisible under normal conditions.
Researchers developed an improved method for G4 landscape determination, revealing that sequence property-specific constraints in the nuclear environment mitigate G4 formation. The technique, AbC G4-ChIP, captures G4s efficiently without bias, showing that depletion of a repeat-binding protein enhances net G4 capture at specific sites.
Researchers studied Prorocentrum cordatum to understand its molecular processes, revealing a unique photosynthetic machinery that may help it adapt to changing light conditions. The findings could lead to improved understanding of harmful algal blooms and their role in climate change.
Researchers at John Innes Centre used cryo-EM to visualize the structural architecture of chloroplast RNA polymerase and build a detailed atomic model. The study reveals new insights into transcription, a fundamental step in making photosynthetic proteins, and how these proteins interact with DNA and mRNA.
A novel mechanism for splicing human short introns has been discovered using the SAP30BP-RBM17 complex. The researchers confirmed that the established pre-mRNA splicing mechanism cannot work in a subset of human short introns.
Researchers from Tokyo University of Science identify Cpeb4 protein's crucial role in mRNA splicing and osteoclast differentiation, shedding light on bone disease mechanisms. The study's findings may lead to new diagnostic techniques and treatments for conditions like osteoporosis.
Researchers at the University of Virginia Health System discovered that tau proteins damage brain cells by warping their nuclei, altering gene function and increasing tau production. This finding could lead to new treatments for Alzheimer's disease and other tauopathies.
Researchers at Dana-Farber Cancer Institute uncover the role of disordered protein regions in controlling chromatin remodeling complexes, shedding light on their contribution to cancer development. The study highlights the importance of sequence-specific interactions within these proteins for proper gene regulation.
Researchers at Kanazawa University found a link between nuclear pore complex alterations and glioblastoma. They demonstrated that NUP107 proteins overexpression degrades the function of p53, a crucial cancer-preventing protein. Further studies are needed to uncover the molecular pathways at play.
Scientists have discovered that small fat-filled lipid droplets can indent and puncture a cell's nucleus, leading to elevated DNA damage. This finding has significant implications for various diseases, including cancer.
Researchers identified midnolin as a protein that degrades short-lived nuclear proteins by directly grabbing them and pulling them into the proteasome. This mechanism is crucial for genes related to brain function, immune system, and development.
SARS-CoV-2's nucleocapsid protein (N) uses human body temperature to replicate, binding to RNA motifs at specific spatial folds. The study reveals new functions and potential targets for antiviral drugs.
A new nano-sized force sensor developed by Tampere University researchers allows for the measurement of intracellular forces and mechanical strains. This technology has great potential for studying cancer cells and understanding cellular mechanics.
Researchers discovered cytoplasmic retinoic acid receptors, such as RARalpha, are essential for T cell linking sensing at the cell surface with downstream signaling cascades and gene expression programs. The study sheds new light on TCR signaling and its connection to cancer treatment.
Rensselaer Polytechnic Institute researchers are using the ring-sheared drop module on the International Space Station to study protein solutions in microgravity. This research will aid in developing predictive models for both fundamental science and industry, including pharmaceutical development.
A team of scientists has identified a key player in the coupling between early transcription termination and RNA degradation. The ARS2 protein recruits ZC3H4, which interacts with the NEXT complex to target nascent transcripts for degradation.
CHOP researchers have developed stable, universal MHC-I molecules that can be produced rapidly at scale, allowing for the development of effective and universal immunotherapies. These engineered MHC-I molecules promote peptide exchange across multiple HLA allotypes, covering various forms.
A study has identified a potential treatment target for prostate cancer that is resistant to hormone therapy, a protein modification involving TRAF4. The researchers found that TRAF4 promotes the spread of cancer and may be associated with a new treatment option for patients.
Researchers have discovered that nuclear pore IDPs form a dynamic barrier that allows essential cellular factors to pass while blocking viruses and pathogens. The team used synthetic biology, multidimensional fluorescence microscopy, and computer-based simulations to study IDPs in living cells.
Researchers at UC Davis discovered how oligodendrocyte-lineage cells transfer cell material to neurons in the mouse brain, providing a new mechanism for understanding brain maturation and finding treatments for neurological conditions. This discovery opens new possibilities for treating neurodegenerative diseases like Alzheimer's and P...
Researchers at Children's Hospital of Philadelphia discovered that viral proteins use phase separation to coordinate the complex process of replicating viral genomes and then encapsulating them in a viral particle. This process allows for the orderly and coordinated formation of infectious viral offspring.
Researchers have uncovered a unique mechanism by which the SV40 virus infects cells by exploiting the nuclear pore complex and LINC protein. This finding may provide insights into the mechanisms underlying cancer-causing pathogens and shed light on basic cell biology.
A new mechanism has been discovered for the passive transport of biomolecules through the nuclear pore complex, with implications for human diseases. The research team used supercomputing simulations on Frontera and Stampede2 systems to study the kinetics of the nuclear pore transport.
Researchers develop NMR spectroscopy method with amplifier for accurate protein detection at physiological concentrations. This allows study of protein dynamics and behavior at native levels, shedding light on cell proliferation to tumor growth.
Using nearly two decades of research and ultrabright X-ray beams, scientists have created a detailed structural map of the nuclear pore complex (NPC), a key regulator of cellular operations. The results provide significant implications for understanding disease mechanisms and developing new treatments.
The nuclear pore complex is a vital gatekeeper for cell operations, controlling DNA entry and exit. A recent study has made significant breakthroughs in understanding its structure and function, shedding light on the complex's role in various diseases.
Researchers use stem cells from people with extra X chromosomes to identify key genes contributing to symptoms like infertility and intellectual disability. The study's findings could lead to new treatments for these conditions.
Researchers have identified a crucial nuclear transport mechanism essential for organ growth and development, involving the protein YAP. The study shows that YAP interacts with importin-7 to control its nuclear entry, regulating cell and tissue growth, and potentially targeting diseases such as atherosclerosis and cancer.
A team of researchers has identified a novel splicing mechanism for human short introns, involving the distinct factor SPF45. This discovery sheds light on alternative splicing and its potential applications in cancer treatment.
Scientists from GIST discovered NSrp70, a gene regulator that plays a crucial role in T cell maturation and development. The absence of NSrp70 leads to uncontrolled cell growth and death, resulting in reduced lymphocyte count and unchecked tumor growth.
The study identifies a correlation between the progression of Alzheimer's disease and nuclear aggregates in brain cells. The findings suggest that these aggregates have a function in manipulating gene expression and may be part of AD pathology.
Scientists developed a 'designer' pore that mimics real nuclear pores, revealing how selectivity is achieved through nucleoporin interactions. The study demonstrates the importance of FG repeats and spacer sequences in determining pore function.
Researchers at Kyoto University's iCeMS have identified a nuclear protein fragment that activates a lipid-scrambling protein to display an 'eat-me' signal on cell surfaces, alerting phagocytes to eliminate unwanted cells. This discovery sheds light on the complex process of cell death and its importance for maintaining tissue health.
Yu-Ting Huang's unexpected finding that ATP can alter human protein folding through destabilization may be relevant in studying cancer cells. Samuel Junod and Joseph Kelich were recognized for their studies of intrinsically disordered proteins' transport routes through nuclear pore complexes.
Researchers have confirmed that variants in the LMNB1 gene cause syndromic microcephaly by disrupting the nuclear envelope, leading to misshapen nuclei and impaired function. The study highlights a new genetic cause of congenital abnormalities and broadens the understanding of laminopathies.
A study published in Nature Communications found that Lem2 is key to nuclear size control in the model organism Schizosaccharomyces pombe. Researchers confirmed Lem2's role by assessing changes in nuclear volume/cytoplasmic volume ratio after deleting or overexpressing the protein.